• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有L-2-羟基戊二酸尿症的儿童的肾母细胞瘤。

Wilms tumor in a child with L-2-hydroxyglutaric aciduria.

作者信息

Rogers Robert E, Deberardinis Ralph J, Klesse Laura J, Boriack Richard L, Margraf Linda R, Rakheja Dinesh

机构信息

1Department of Pathology, Children's Medical Center, Dallas, TX, USA.

出版信息

Pediatr Dev Pathol. 2010 Sep-Oct;13(5):408-11. doi: 10.2350/09-12-0768-CR.1. Epub 2010 Jan 11.

DOI:10.2350/09-12-0768-CR.1
PMID:20064066
Abstract

We report a male infant with L-2-hydroxyglutaric aciduria and Wilms tumor. L-2-hydroxyglutaric aciduria is a rare, autosomal-recessive, inborn error of metabolism characterized by a variable degree of progressive encephalopathy. Of the fewer than 100 cases reported in the literature, at least 9 patients have developed tumors of the central nervous system. To our knowledge, the present case is the 1st example of an extracranial tumor associated with L-2-hydroxyglutaric aciduria. This observation potentially widens the tumor spectrum in this metabolic disorder and may lead to further insight into the relationship between L-2-hydroxyglutaric acid and cellular transformation.

摘要

我们报告了一名患有L-2-羟基戊二酸尿症和肾母细胞瘤的男婴。L-2-羟基戊二酸尿症是一种罕见的常染色体隐性遗传的先天性代谢紊乱疾病,其特征为不同程度的进行性脑病。在文献报道的不到100例病例中,至少有9名患者发生了中枢神经系统肿瘤。据我们所知,本病例是与L-2-羟基戊二酸尿症相关的颅外肿瘤的首例。这一观察结果可能会扩大这种代谢紊乱疾病中的肿瘤谱,并可能有助于进一步深入了解L-2-羟基戊二酸与细胞转化之间的关系。

相似文献

1
Wilms tumor in a child with L-2-hydroxyglutaric aciduria.患有L-2-羟基戊二酸尿症的儿童的肾母细胞瘤。
Pediatr Dev Pathol. 2010 Sep-Oct;13(5):408-11. doi: 10.2350/09-12-0768-CR.1. Epub 2010 Jan 11.
2
[Treatment of Wilms' tumor using surgery, chemotherapy and delayed radiotherapy in stages II-IV].[采用手术、化疗及延迟放疗治疗II-IV期肾母细胞瘤]
Bol Med Hosp Infant Mex. 1988 May;45(5):284-91.
3
Brief report: biliary emesis as the presenting sign in a neonate with Wilms tumor.简短报告:以胆汁性呕吐为首发症状的新生儿肾母细胞瘤
Med Pediatr Oncol. 2002 May;38(5):374-5. doi: 10.1002/mpo.1352.
4
Adult Wilms' tumor.成人肾母细胞瘤。
Saudi J Kidney Dis Transpl. 2009 Sep;20(5):835-7.
5
Combined D-2- and L-2-hydroxyglutaric aciduria with neonatal onset encephalopathy: a third biochemical variant of 2-hydroxyglutaric aciduria?合并D-2-和L-2-羟基戊二酸尿症伴新生儿期发病的脑病:2-羟基戊二酸尿症的第三种生化变异型?
Neuropediatrics. 2000 Jun;31(3):137-40. doi: 10.1055/s-2000-7497.
6
[Treatment of Wilms' tumor].[肾母细胞瘤的治疗]
Rev Chil Pediatr. 1987 May-Jun;58(3):216-9.
7
Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.非转移性肾母细胞瘤治疗中即刻肾切除术与术前化疗的比较:英国儿童癌症研究组的一项随机试验(UKW3)结果
Eur J Cancer. 2006 Oct;42(15):2554-62. doi: 10.1016/j.ejca.2006.05.026. Epub 2006 Aug 10.
8
[Treatment of advanced Wilms' tumor].[晚期肾母细胞瘤的治疗]
Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):791-5.
9
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.间变性组织学肾母细胞瘤的治疗:第五届全国肾母细胞瘤研究结果
J Clin Oncol. 2006 May 20;24(15):2352-8. doi: 10.1200/JCO.2005.04.7852.
10
Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.肾衰竭并不妨碍接受化疗的儿童肾母细胞瘤的治愈:来自国家肾母细胞瘤研究组的报告
Pediatr Blood Cancer. 2008 Feb;50(2):242-5. doi: 10.1002/pbc.21229.

引用本文的文献

1
L-2-hydroxyglutarate impairs neuronal differentiation through epigenetic activation of expression.L-2-羟基戊二酸通过基因表达的表观遗传激活损害神经元分化。
bioRxiv. 2025 Jun 24:2025.04.16.649033. doi: 10.1101/2025.04.16.649033.
2
Fast, sensitive LC-MS resolution of -hydroxy acid biomarkers via SPP-teicoplanin and an alternative UV detection approach.通过 SPP-替考拉宁和替代 UV 检测方法实现 -羟基酸生物标志物的快速、灵敏 LC-MS 分离。
Anal Bioanal Chem. 2024 May;416(12):3007-3017. doi: 10.1007/s00216-024-05248-2. Epub 2024 Apr 3.
3
Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy.
新陈代谢与表观遗传学之间的联系:机制与新型抗癌策略。
Front Pharmacol. 2022 Jul 22;13:935536. doi: 10.3389/fphar.2022.935536. eCollection 2022.
4
Evaluation of clinical, neuroradiologic, and genotypic features of patients with L-2-hydroxyglutaric aciduria.L-2-羟基戊二酸尿症患者的临床、神经放射学和基因型特征评估。
Turk Pediatri Ars. 2020 Sep 23;55(3):290-298. doi: 10.14744/TurkPediatriArs.2019.06926. eCollection 2020.
5
Glutamine reliance in cell metabolism.谷氨酰胺在细胞代谢中的依赖性。
Exp Mol Med. 2020 Sep;52(9):1496-1516. doi: 10.1038/s12276-020-00504-8. Epub 2020 Sep 17.
6
Mitochondrial TCA cycle metabolites control physiology and disease.线粒体三羧酸循环代谢物控制着生理和疾病。
Nat Commun. 2020 Jan 3;11(1):102. doi: 10.1038/s41467-019-13668-3.
7
Oncometabolites in renal cancer.肾细胞癌中的代谢物。
Nat Rev Nephrol. 2020 Mar;16(3):156-172. doi: 10.1038/s41581-019-0210-z. Epub 2019 Oct 21.
8
Clinicoradiological Spectrum of L-2-Hydroxy Glutaric Aciduria: Typical and Atypical Findings in an Indian Cohort.L-2-羟基戊二酸尿症的临床放射学谱:印度队列中的典型和非典型表现
J Clin Imaging Sci. 2019 Feb 27;9:3. doi: 10.25259/JCIS-9-3. eCollection 2019.
9
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma.抗坏血酸诱导的 TET 激活减轻肾细胞癌中羟甲基胞嘧啶的不良丢失。
J Clin Invest. 2019 Mar 4;129(4):1612-1625. doi: 10.1172/JCI98747.
10
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer.探讨 L-2-羟戊二酸的生化和表观遗传机制:肾癌潜在的治疗靶点
Clin Cancer Res. 2018 Dec 15;24(24):6433-6446. doi: 10.1158/1078-0432.CCR-18-1727. Epub 2018 Aug 14.